Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis

Neuroscience

Volumn 189, Issue , 2011, Pages 337-344

  Cid, M P ^a   Vilcaes, A A ^a   Rupil, L L ^a   Salvatierra, N A ^a   Roth, G A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Autoimmunity; GABAergic system; Multiple sclerosis; Neurotransmitter release; Synapsin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOPYRIDINE; CALCIUM ION; FLUNITRAZEPAM; GLUTAMIC ACID; PICROTOXIN; SYNAPSIN I;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; FRONTAL CORTEX; GABAERGIC SYSTEM; MULTIPLE SCLEROSIS; NEOCORTEX; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SYNAPTOSOME; WISTAR RAT;

4-AMINOPYRIDINE; ANIMALS; CALCIUM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLUNITRAZEPAM; FRONTAL LOBE; GABA ANTAGONISTS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; NERVE ENDINGS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SYNAPSINS; SYNAPTOSOMES;

EID: 79960922534     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.005     Document Type: Article

References (45)

1. Bhat R., Axtell R., Mitra A., Miranda M., Lock C., Tsien R.W., Steinman L. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A 2010, 107:2580-2585.
2. Bhatt S., Zalcman S., Hassanain M., Siegel A. Cytokine modulation of defensive rage behavior in the cat: role of GABAA and interleukin-2 receptors in the medial hypothalamus. Neuroscience 2005, 133:17-28.
3. Bolton C., Paul C. Glutamate receptors in neuroinflammatory demyelinating disease. Mediators Inflamm 2006, 2006:1-12. ID 93684.
4. Calabrese M., Rinaldi F., Mattisi I., Grossi P., Favaretto A., Atzori M., Bernardi V., Barachino L., Romualdi C., Rinaldi L., Perini P., Gallo P. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology 2010, 74:321-328.
5. Cesca F., Baldelli P., Valtorta F., Benfenati F. The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 2010, 91:313-348.
6. Chalifoux J.R., Carter A.G. GABAB receptor modulation of voltage-sensitive calcium channels in spines and dendrites. J Neurosci 2011, 31:4221-4232.
7. Chang A., Smith M.C., Yin X., Fox R.J., Staugaitis S.M., Trapp B.D. Neurogenesis in the chronic lesions of multiple sclerosis. Brain 2008, 131:2366-2375.
8. Cid M.P., Arce A., Salvatierra N.A. Acute stress or systemic insulin injection increases flunitrazepam sensitive-GABAA receptor density in synaptosomes of chick forebrain: modulation by systemic epinephrine. Stress 2008, 11:101-107.
9. Degano A.L., Roth G.A. Passive transfer of experimental autoimmune encephalomyelitis in Wistar rats: dissociation of clinical symptoms and biochemical alterations. J Neurosci Res 2000, 59:283-290.
10. Demakova E.V., Korobov V.P., Lemkina L.M. Determination of gamma-aminobutyric acid concentration and activity of glutamate decarboxylase in blood serum of patients with multiple sclerosis. Klin Lab Diagn 2003, 4:15-17.
11. Dunkley P.R., Heath J.W., Harrison S.M., Jarvie P.E., Glenfield P.J., Rostas J.A. A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res 1988, 441:59-71.
12. Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., Gudz T., Macklin W.B., Lewis D.A., Fox R.J., Rudick R., Mirnics K., Trapp B.D. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006, 59:478-489.
13. Frischer M.J., Bramow S., Dal-Bianco A., Lucchinetti C.F., Rauschka H., Schmidbauer M., Laursen H., Soelberg Sorensen P., Lassmann H. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132:1175-1189.
14. González-Burgos G., Hashimoto T., Lewis D.A. Inhibition and timing in cortical neural circuits. Am J Psychiatry 2007, 164:12.
15. Gottesfeld Z., Teitelbaum D., Webb C., Arnon R. Changes in the GABA system in experimental allergic encephalomyelitis-induced paralysis. J Neurochem 1976, 27:695-699.
16. Ishibashi M., Sakai T., Matsuishi T., Yonekura Y., Yamashita Y., Abe T., Ohnishi Y., Hayabuchi N. Decreased benzodiazepine receptor binding in Machado-Joseph disease. J Nucl Med 1998, 39:1518-1520.
17. Jacob T.C., Moss S.J., Jurd R. GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci 2008, 9:331-343.
18. Jang I.S., Jeong H.J., Akaike N. Contribution of the Na-K-Cl cotransporter on GABAA receptor-mediated presynaptic depolarization in excitatory nerve terminals. J Neurosci 2001, 21:5962-5972.
19. Jang I.S., Nakamura M., Ito Y., Akaike N. Presynaptic GABAA receptors facilitate spontaneous glutamate release from presynaptic terminals on mechanically dissociated rat CA3 pyramidal neurons. Neuroscience 2006, 138:25-35.
20. Jovanovic J.N., Benfenati F., Siow Y.L., Sihra T.S., Sanghera J.S., Pelech S.L., Greengard P., Czernik A.J. Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci U S A 1996, 93:3679-3683.
21. Jovanovic J.N., Sihra T.S., Nairn A.C., Hemmings H.C., Greengard P., Czernik A.J. Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals. J Neurosci 2001, 15:7944-7953.
22. Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res 1984, 320:65-98.
23. Korshoej A.R., Holm M.M., Jensen K., Lambert J.D.C. Kinetic analysis of evoked IPSCs discloses mechanism of antagonism of synaptic GABA A receptors by picrotoxin. Br J Pharmacol 2010, 159:636-649.
24. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Brück W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
25. Lewitus G.M., Zhu J., Xiong H., Hallworth R., Kipnis J. CD4+CD25-effector T-cells inhibit hippocampal long-term potentiation in vitro. Eur J Neurosci 2007, 26:1399-1406.
26. Long P., Mercer A., Begum R., Stephens G.J., Sihra T.S., Jovanovic J.N. Nerve terminal GABAA receptors activate Ca2+/calmodulin-dependent signaling to inhibit voltage-gated Ca2+ influx and glutamate release. J Biol Chem 2009, 284:8726-8737.
27. Manson S.C., Wegner C., Filippi M., Barkhof F., Beckmann C., Ciccarelli O., De Stefano N., Enzinger C., Fazekas F., Agosta F., Gass A., Hirsch J., Johansen-Berg H., Kappos L., Korteweg T., Polman C., Mancini L., Manfredonia F., Marino S., Miller D.H., Montalban X., Palace J., Rocca M., Ropele S., Rovira A., Smith S., Thompson A., Thornton J., Yousry T., Frank J.A., Matthews P.M. Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res 2008, 187:25-31.
28. Manyam N.V., Katz L., Hare T.A., Gerber J.C. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Arch Neurol 1980, 37:352-355.
29. Möhler H. Role of GABAA receptors in cognition. Biochem Soc Trans 2009, 37:1328-1333.
30. Nakamura M., Sekino Y., Manabe T. GABAergic interneurons facilitate the mossy fiber excitability in the developing hippocampus. J Neurosci 2007, 27:1365-1373.
31. Nicholls D.G. Bioenergetics and transmitter release in the isolated nerve terminal. Neurochem Res 2003, 28:1433-1441.
32. Nicholls D.G., Sihra T.S., Sánchez-Prieto J. Calcium-dependent and -independent release of glutamate monitored by continuous fluorometry. J Neurochem 1987, 49:50-57.
33. Paparrigopoulos T., Ferentinos P., Kouzoupis A., Koutsis G., Papadimitriou G.N. The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry 2010, 22:14-21.
34. Pinborg L.H., Videbæk C., Hasselbalch S.G., Sørensen S.A., Wagner A., Paulson O.B., Knudsen G.M. Benzodiazepine receptor quantification in Huntington's disease with [123I]iomazenil and SPECT. J Neurol Neurosurg Psychiatry 2001, 70:657-661.
35. Primus R.J., Kellogg C.K. Experience influences environmental modulation of function at the benzodiazepine/GABAA receptor chloride channel complex. Brain Res 1991, 545:257-264.
36. Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, Mandolesi G, De Ceglia R, Maida S, Biffi E, Pedrocchi A, Menegon A, Bernardi G, Furlan R, Martino G, Centonze D (in press) Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun. doi:10.1016/j.bbi.2010.10.004.
37. Rudolf J., Sobesky J., Ghaemi M., Heiss W.D. The correlation between cerebral glucose metabolism and benzodiazepine receptor density in the acute vegetative state. Eur J Neurol 2002, 9:671-677.
38. Slavin D.A., Bucher A.E., Degano A.L., Soria N.W., Roth G.A. Time course of biochemical and immunohistological alterations during experimental allergic encephalomyelitis. Neurochem Int 1996, 29:597-605.
39. Tibbs G.R., Barrie A.P., Van Mieghem F.J., McMahon H.T., Nicholls D.G. Repetitive action potentials in isolated nerve terminals in the presence of 4-aminopyridine: effects on cytosolic free Ca2+ and glutamate release. J Neurochem 1989, 53:1693-1699.
40. Turecek R., Trussell L.O. Reciprocal developmental regulation of presynaptic ionotropic receptors. Proc Natl Acad Sci U S A 2002, 99:13884-13889.
41. Vereker E., O'Donnell E., Lynch M.A. The inhibitory effect of interleukin-1β on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J Neurosci 2000, 20:6811-6819.
42. Vilcaes A.A., Furlan G., Roth G.A. Inhibition of Ca2+-dependent glutamate release in cerebral cortex synaptosomes of rats with experimental autoimmune encephalomyelitis. J Neurochem 2009, 108:881-890.
43. Wegner C., Esiri M.M., Chance S.A., Palace J., Matthews P.M. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006, 67:960-967.
44. Zhang N., Wei W., Mody I., Houser C.R. Altered localization of GABAA receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J Neurosci 2007, 27:7520-7531.
45. Zipoli V., Goretti B., Hakiki B., Siracusa G., Sorbi S., Portaccio E., Amato M.P. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult Scler 2010, 16:62-67.